MAPT and Alzheimer disease: In summary, our study 1. confirms and suggests novel biomarker candidates associated with Aβ and tau PET, 2. shows the temporal profile of different groups of CSF proteins across the AD continuum in three independent cohorts and 3. highlights the dynamic nature of proteomic changes.